GlassScriptPhysician profile
George B Boline
NPI 1396745436
$4,025.84
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,543 · 2020: $346 · 2021: $673 · 2022: $1,447 · 2023: $16.55.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $16.55.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $16.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,411.25 | 2021-2022 | |
| Neotract INC. | $1,227.26 | 2019 | |
| Astellas Pharma US INC | $577.37 | 2019-2021 | |
| Allergan, INC. | $226.97 | 2020-2021 | |
| Abbvie INC. | $154.92 | 2019-2022 | |
| Boston Scientific Corporation | $113.41 | 2019 | |
| Urogen Pharma, INC. | $55.22 | 2022-2023 | Jelmyto |
| Pfizer INC. | $54.31 | 2019-2021 | |
| Ferring Pharmaceuticals INC. | $53.75 | 2019-2020 | |
| Janssen Biotech, INC. | $39.75 | 2019 | |
| Palette Life Sciences, INC. | $25.80 | 2022 | |
| Tolmar Pharmaceuticals, INC. | $23.90 | 2021 | |
| Urovant Sciences INC | $18.52 | 2021 | |
| Dendreon Pharmaceuticals LLC | $18.12 | 2019 | |
| Coloplast Corp | $13.42 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axonics, INC. | $11.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Boline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.